Mr Bearbull 

Time’s up for Glaxo

Mr Bearbull

Mr Bearbull
Time’s up for Glaxo

Shareholders in GlaxoSmithKline (GSK) really only have to answer one question: will they benefit when the group is taken over or broken up? There seems little hope that Glaxo can arrest its decline through its own efforts, therefore the responsibility will fall to a third party. Will that be good for shareholders, or should they exit now before the share price, which has been sinking for years, is blown out of the water by the dividend cut that looks just one corporate foul-up away?

To continue reading, register today

to enjoy limited access to the following:

  • Daily trading news
  • Funds coverage
  • Features on big investment themes
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now